Ligand validation:5GNY

BGC: beta-D-glucopyranose

BGC is a Ligand Of Interest in 5GNY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5GNY_BGC_A_501	44%	43%	0.191	0.921	0.59	1.58	-	2	2	0	100%	0.688
5GNY_BGC_B_501	16%	56%	0.314	0.889	0.47	1.19	-	1	2	0	100%	0.715
5GNY_BGC_C_501	10%	55%	0.311	0.824	0.38	1.35	-	1	2	0	100%	0.693
5GNY_BGC_D_501	7%	59%	0.334	0.797	0.5	1.04	-	-	2	0	100%	0.767
5GNX_BGC_A_502	53%	46%	0.119	0.879	0.79	1.27	-	1	3	0	100%	1
5GNZ_BGC_A_501	23%	48%	0.246	0.869	0.76	1.23	-	2	3	0	100%	0.807
8W8V_BGC_A_501	100%	70%	0.023	0.996	0.4	0.76	-	-	0	0	100%	1
5DVI_BGC_B_501	100%	57%	0.027	0.991	0.74	0.9	-	-	0	0	100%	1
1HHU_BGC_C_8	100%	67%	0.037	0.997	0.6	0.68	-	-	0	0	100%	1
9G11_BGC_A_601	100%	46%	0.037	0.995	1.24	0.84	1	-	1	0	100%	1
4IIG_BGC_B_950	100%	50%	0.035	0.987	0.78	1.13	-	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.